Code of Conduct

Pharmacist-Biochemistry, Master and PhD from the Faculty of Pharmaceutical Sciences-USP. She was head of the Department of Pharmacy, Deputy Director and Director of the Faculty of Pharmacy in two terms. She was president of the FURP Deliberative Council. She coordinated FCF’s Environmental Management Project and USP’s participation in the Drug Advertising Monitoring Project with ANVISA. She was Coordinator of TCC of the Brazilian Pharmacopoeia, Stakeholder of the US Pharmacopeia, Coordinator of CONFAR and President Director of the Instituto Pesquisas Farmacêuticas Foundation (FIPPARMA). Among other honors, she received the IPS Medal Award from the International Pharmaceutical Federation (FIP) in Basel; in Brasilia, the Commendation of Pharmaceutical Merit from the Federal Council of Pharmacy. She was patron of FCF graduates. She is a member of the Brazilian Academy of Pharmaceutical Sciences, a Brazilian reference in the pharmaceutical field. It maintains intense academic activity, with research projects and partnerships at national and international level.

http://lattes.cnpq.br/8115987312003585

Michel Durand Mura is currently Managing Partner and main shareholder of MURAM Assessoria Empresarial Ltda, a consulting company focused on business development and M&A activities in the pharmaceutical area in Latin America. He is a permanent member of the Board of Directors of the CCFB (France-Brazil Chamber of Commerce) and former president of the same organization (2005-2009) and of Eurocamaras (2006-2007). He was a founding member of Interfarma as a representative of the European Group.
French and Mexican by naturalization, he graduated in 1968 with an MBA from HEC (École des Hautes Études Commerciales). From 1969 to 1974, he served as Assistant to the Director of Human Resources at the Canadian Ministry of Transport in Quebec (1969-70). Between 1970 and 1972, in Mexico, he was Commercial Director of Vitaminas y Minerales Complementarios S.A (animal nutrition), and General Manager and main shareholder of Start Computación SA (informatics), also in Mexico, between 1972 and 1974.
In 1974, while still in Mexico, he joined the Hoechst Group as Administrative and Financial Director of the Roussel Group. In 1976, he became Deputy General Manager and, from 1980 to 1982, General Manager. From 1983 to 1992, he was simultaneously President of two Brazilian companies of the Roussel Group: SARSA – Laboratório Silva Araújo Roussel S.A. and Chemo – Chemical Products Com. Ind. S.A., both in Rio de Janeirol. From 1989, he also accumulated responsibilities in the pharmaceutical and agricultural divisions as Vice President of Hoechst do Brasil. In 1992, Michel Durand Mura was appointed General Manager for Latin America at Groupe Roussel Uclaf. From July 1994 to July 1995, he was President of Hoechst do Brasil. After the formation of Hoechst Marion Roussel, a pharmaceutical company of the Hoechst Group, he was appointed President for Latin America and member of the Executive Committee, a position he held from July 1995 to December 1999.

Aventis, the result of the merger between Hoechst and Rhône Poulenc, confirmed Michel Durand Mura as President in Latin America and member of OPCOM (Operations Committee), a position he held until May 31, 2005, when he retired, after a transition from year as Regional President of the newly created Sanofi-Aventis Group.

In 2007, Michel Durand Mura was named a Chevalier of the French Legion of Honor.

Born in São Paulo, age 64, lawyer registered with the OAB/SP under n. 75,318, employee of the Brazilian unit of the Boehringer Ingelheim group for 40 years, having initially acted as responsible for organizing documents for bids and later for the Tax and Legal areas and, interim, DRH.

As responsible for the Legal area, I had the opportunity to experience important facts that changed the course of the pharmaceutical sector in Brazil, such as the creation of ANVISA and CMED, CPI on Medicines, patent legislation, among others.

I participated in the creation of Interfarma’s Code of Conduct, under the coordination of my colleague Ronaldo Pires, as well as the current Department of Compliance and Ethics at Boehringer.

He is a Doctor in Medicine and Full Professor at the Faculty of Medicine of the University of São Paulo, USP. He was Director of Communication (2021-2022) at the Brazilian Federation of Gastroenterology, FBG; member of the American College of Physicians and the American College of Gastroenterology. He has 150 works published in Brazil and abroad. Author of six books on Medicine/Gastroenterology. He was also Medical Director at Merck Sharp & Dohme and Executive Medical Director, also at MSD. He also sees patients in a private clinic.

Eduardo Najjar Roque graduated in Law in 1977.
He has several courses, including the Pfizer Leadership Development Program, held at Harvard University.
He has over 35 years of experience working as a lawyer at Pfizer-Brasil (Laboratório Pfizer Ltda), where he held positions as Director of Legal and Corporate Affairs.
He actively participated in the acquisition and integration processes of Parke-Davis / Warner-Lambert, Pharmacia and Wyeth.
He was a member of INTERFARMA’s Audit Committee and is currently a member of the Ethics Committee of said entity.
Currently, he provides business consulting services, as well as takes care of family businesses in the management of assets.

Alex Dalmasso is one of the most renowned compliance professionals in Brazil, working in legal and compliance departments of large multinational companies for the last 27 years, leading them for the last 22 years and leading Compliance departments for the last 14 years. In addition to his solid academic background at renowned colleges in Brazil, his educational highlights include two MBAs in Business Law and Audit and Controls, Policy and Strategy from the Higher Graduate Association of the Escola de Guerra and Compliance Certification from Seton Hall University.

His legal milestones include two mergers, production outsourcing agreements, the sale of two factories, the negotiation of 21 products, as well as a wide range of licensing and distribution agreements. In the compliance area, a direct participation in the implementation of a robust compliance program resulting from a conduct adjustment term and a consent decree in the USA, the elaboration of a compliance manual for emerging markets and the creation of guidelines to classify third parties and carry out the corresponding due diligences, globally.

Alex regularly participates in various national and international compliance congresses and is up-to-date with the latest compliance trends around the world. Alex is a leading compliance thought leader.

Alex is fluent in Portuguese, English, Spanish, French and Italian. He also has notions of Japanese, German and Russian.

Alex has dual nationality: Brazilian and Italian.

Alex was elected as one of the 20 most admired compliance directors in Brazil by the LEC in Dec / 2018.

Devaney Baccarin is a pharmacist-biochemist graduated from USP, a journalist from Fundação Cásper Líbero and has an MBA in strategic management from ITA-ESPM.

He worked for 38 years in the pharmaceutical industry, starting his career in technical areas such as quality assurance and production, rising successively to sales force, market research and productivity, human resources, marketing, corporate affairs and presidencies.

Companies where he has been a senior manager and director include Merrell Lepetit, Schering, Roche, Wyeth and Eli Lilly.

He was president of four companies: Whitehall (Wyeth Consumer), Genzyme, Astellas and Recordati Rare Diseases, with the latter two responsible for starting operations in Brazil.

After three decades as an industry executive, he established his own consultancy, Baccarind Assessoria Empresarial, where he worked with clients on M&A projects, regulatory affairs and logistics optimization.

Devaney had an associative role in the various entities of the pharmaceutical industry, having held the presidency of ABIMIP, and member of the boards of Sindusfarma, Febrafarma and three terms as head of the board of Interfarma. He was the first president of Interfarma’s access commission, a successful commission in a series of claims that resulted in the creation of CONITEC.

He holds a chair as an academician of the Brazilian Academy of Pharmaceutical Sciences – National Academy of Pharmacy.

Devaney is currently a partner at Odgers Berndtson Executive Search for the areas of life science & healthcare.

Born in São Paulo in 1964. At the end of 1983, I joined the Boehringer Ingelheim pharmaceutical company in Brazil, as an assistant in the legal department, responsible for obtaining and maintaining documents for the company’s qualification in bidding procedures. In 1989 I graduated in Law and Social Sciences from FMU – Faculdades Metropolitanas Unidas, registered with the OAB/SP under number 107.743 in 1990. In 1996 I took a specialization course in Business Law at Universidade Mackenzie. In 2003 I took a specialization course in Labor Law and Labor Procedural Law – Mascaro and Mannrich Center for Cultural Development. I remained at Boehringer Ingelheim do Brasil until 01.01.2019, always working in the legal area, having held several positions, the last of which, from September 2014, as Senior Compliance Manager – Compliance Officer, when I had the opportunity to be the responsible for the local implementation of the Company’s Global Compliance Program, including participation in Commissions with Interfarma, as Compliance Commission and also in its Ethics Council, as Internal Counselor.

Marcos Lobo de Freitas Levy graduated in Law from the University of São Paulo in 1977 and has more than 40 years of experience working as an in-house lawyer for large companies and as an external consultant. He is the author of several articles, published in various media, on pharmaceutical regulatory, business ethics, and intellectual property. The articles are also published on the blog www.MarcosLevy.blogspot.com.br
He was Legal and Corporate Affairs Director at MSD (Merck Sharp & Dohme), Legal Director and “Associate General Cousel” at Pharmacia Brasil and Institutional Relations Director at Boehringer Ingelheim.
He is a member of the Latin American Association of Ethics in Business and Economics, being Vice President of the Association from 2002 to 2003 and President from 2003 to 2005.
His work in the Life Sciences area has been recognized by the publications: “Who is Who Legal”, “Chambers & Partners Expert Guides”, “Global Health & Pharma”, “Leaders League” and “Best Lawyers in Brazil”®.
He is co-author of the “International Comparative Legal Guide on Pharmaceutical Advertising” (from 2015 to 2020) and of the Brazilian chapter of the “Global Chambers Practice Guide in Life Sciences”, published in 2018. He is also co-author of the “Chambers Global Practice Guides – Pharmaceutical Advertising” published in 2021 and 2022.

Lawyer with 20 years of professional experience, 14 of which in the pharmaceutical industry.
Currently Legal Director and Compliance Officer at Novo Nordisk do Brasil (since 2019).

Ana has been Healthcare Compliance Senior Manager and Data Privacy Officer for Amgen Brazil and Bergamo since August 2018. As the lead representative of WC&BE (Worldwide Compliance & Business Ethics) in the Brazilian branch, Ana’s focus is on addressing associated Healthcare Compliance issues to Amgen’s operations in Brazil, including compliance with interactions with the Healthcare community and with anti-corruption and bribery laws. In her role, she is responsible for identifying, screening, coordinating and leading compliance-related activities between Brazil and various business functions, as well as responsible for Privacy / Data Protection issues.

Ana began her career in the Audit function at Deloitte Touche Tohmatsu and then transitioned to the pharmaceutical industry, joining Roche Brazil for over 10 years, initially as Internal Audit Coordinator in the financial division and later as Corporate Compliance Manager in charge of by all elements of Roche’s local compliance program in Brazil.

Ana holds a degree in Accounting from the Pontifical Catholic University, a postgraduate degree in Business Administration from the Brazilian Institute of Capital Markets (IBMEC), a specialization in Compliance and Corporate Governance from the Institute of Education and Investigation in São Paulo (INSPER), and Certification (CCEP-I) by the Society for Compliance and Business Ethics.

Pharmacist and Biochemistry graduated from Universidade Estadual Paulista Júlio de Mesquita Filho (UNESP), in 2003. Specialist in industrial administration from Fundação Vanzolini, with 19 years of professional experience in the Pharmaceutical Industry

Compliance Director and Data Privacy Officer at Eli Lilly since 2019. He worked in the areas of Quality, Human Resources and Six Sigma Black Belt.

Director of Health Care Compliance at Janssen Brasil, internationally certified professional in Compliance and Ethics by the Society of Corporate Compliance and Ethics (SCCE), graduated in Information Technology at Mackenzie and post-graduated in System Analysis (Mackenzie), Project Management ( FIAP) and MBA in Strategic Management from FGV.

Experience in business integrity since 2011, initially as responsible for Compliance and Technology Integration for the Latin America region at J&J and, since 2017, acting as Compliance Officer for Janssen Brasil.

Established the new Compliance structure based on the pillars of Prevention, Detection and Correction, with the program awarded by the business area given its importance and impact on Janssen’s culture in Brazil and Latin America.

Diretora de Compliance na Pfizer Brasil desde 2017, possui 18 anos de experiência em Compliance e áreas relacionadas à governança, dos quais os últimos 14 anos são em posição de liderança em Compliance na Indústria farmacêutica.

Formada em Administração de empresas e com MBA em gestão estratégica e econômica de negócios pela EAESP-FGV, além de ser certificada como Green Belt- Lean Sic Sigma, tem um perfil orientado para a parceria e empoderamento do negócio, pois acredita que grandes resultados vêm de grandes ações com responsabilidade, liderança por exemplo e valores como INTEGRIDADE e coragem.

Já foi nomeada por duas vezes, pelos seus pares, como uma das 20 profissionais de Compliance mais admiradas no Brasil, pelo Compliace On Top e têm disseminado seu conhecimento anualmente como palestrante em eventos de Compliance e governança amplamente reconhecidos (ex. Congresso Anual da LEC, Latam Experience, entre outros).

Eduardo Goto currently holds the position of Senior Manager of Ethics, Risk & Compliance (ERC) at Novartis Brazil. He has 16 years of professional experience, of which more than 12 years in the Health Care / Pharmaceutical Industry.

He has more than 9 years of experience in Compliance, having worked in different industries and positions, with emphasis on implementation / management of Compliance programs for the Medical Devices / Orthopedics industry; investigation of high-risk and high-impact fraud and conducting audits focused on FCPA risks, both internally and at suppliers/distributors in various countries; and recently acts as a strategic partner of Ethics, Risk & Compliance in the pharmaceutical industry.

Compliance specialist, having been internationally certified as Certified Compliance & Ethics Professional – International (CCEP-I) by the Society of Corporate Compliance and Ethics (SCCE).

Graduated in Law from the University of São Paulo (USP) and in Biological Sciences – Medical Modality (UNIFESP), he holds a Master’s Degree in Health Sciences (UNIFESP), and has participated in several courses and certifications in Compliance such as the Latin American Health Care Compliance Certificate Program ( University of Miami), Latin America Health Care Compliance Certification Program (Seton Hall School of Law),

SCCE Basic Compliance Academy and IACA International Anti-Corruption Summer Academy.

Graduated in Business Administration from Universidade Presbiteriana Mackenzie, post-graduated in Administration from INSPER and certified by the Society of Corporate Compliance and Ethics (SCCE) – CCEP-I.

Acting in Compliance since 2012 in pharmaceutical and medical device industries. Responsible for the Compliance program at Boehringer Ingelheim Brasil, acting as Local Compliance Officer.

Graduated in Nursing and Midwifery from the University of São Paulo (1995/1998), she initially worked as a nurse in the Intensive Care Unit in large services such as Hospital das Clínicas da FMUSP, Beneficência Portuguesa, Hospital Bandeirantes and Hospital Oswaldo Cruz (1999 – 2002) . After this period, he began his career in clinical research, acting as manager of research centers across the country in a SMO (Site Management Organization), having, therefore, his first contact with the pharmaceutical industry (2003-2006), joining at Roche in early 2006, then as a clinical research monitor. Also working as Training Coordinator and Line Manager in the Clinical Operations department, she decided to improve her skills in people management and started her MBA at Fundação Getúlio Vargas (FGV) in People Management with an emphasis on Organizational Leadership (2012-2014) .

Also in 2014, she started to work in the Compliance area, taking over as manager of Healthcare Compliance in the company. In 2016, she took over the area as Healthcare Compliance Officer, developing the Healthcare Compliance Program, providing strategic and operational support to the most diverse teams, always focusing on efforts to further strengthen the company’s ethical values and integrity.

Lawyer with 18 years of professional experience, of which more than 15 years in the Pharmaceutical Industry.

Compliance Specialist, internationally certified as a Compliance & Ethics Professional (CCEP-I) by the Society of Corporate Compliance and Ethics (SCCE).

Graduated in Law from Universidade Presbiteriana Mackenzie, post-graduated in Business Law from Fundação Getúlio Vargas – FGV and has specialization courses in Compliance and related topics from the University of Miami (Latin America Health Care Compliance Certificate), University of Toronto (Internal Auditing & Compliance), Harvard Extension School (Internet & Society: Technology & Politics of Control), Pontifical Catholic University of São Paulo – PUC (Compliance) and New York State Bar Association (Advanced Compliance Certificate).

Natasha is currently the Director of Compliance & Ethics at Teva Farmacêutica, being responsible for Compliance and Data Privacy Programs in Brazil and, on an interim basis, in Peru.

Director of Business Ethics and Integrity, leading the Healthcare Compliance strategy and managing the Ethics and Integrity Program at Sanofi Brasil since 2020. She has 25 years of robust and diverse experience in the Pharmaceutical industry in areas such as Regulatory Affairs, Clinical Research, Pharmacovigilance, Quality, Internal Audit, Marketing, Government Sales and Government Affairs, operating locally and regionally (Latin America).

Graduated in Pharmacy and Biochemistry from the University of São Paulo, with an MBA in Marketing from Escola Superior de Propaganda e Marketing, CPC-A Certification from Fundação Getúlio Vargas and Certification in Healthcare Compliance from INSEAD, her profile is oriented towards finding innovative solutions and establishing constructive internal and external partnerships based on business ethics and integrity for better patient care.

Graduated in Law from the Pontifical Catholic University of São Paulo (PUC-SP) in 1998 and LL.M in Corporate/Finance Law from Insper (IBMEC) in 2005. He also has a specialization in Health Compliance from the Brazilian College of Health Executives in 2018; more than 25 years of professional experience in a first-rate and multinational law firm in the medical-hospital equipment, pharmaceutical and biotechnology segment; extensive experience in leading local and regional strategic projects as Chief Legal Officer; responsible for the Legal Department in Brazil and Latin America, leading internal and external teams, working in all areas of law, with emphasis on corporate, civil, antitrust, contractual, tax and criminal law; permanent member of the Executive Committee Brazil and Latin America and responsible for the Department of Ethics and Integrity; extensive experience in compliance programs including FCPA (Foreign Corrupt Practice Act) and UK Bribery Act; responsible for coordinating and reviewing local and regional compliance programs and member of the global Compliance team.